STOCKHOLM, Feb. 12, 2025 /PRNewswire/ — Diamyd Medical will receive USD 1.75 million in expanded collaboration support from Breakthrough T1D (formerly JDRF), the world’s leading Type 1 Diabetes research and advocacy organization, in support of the DIAGNODE-3 Phase 3 trial to facilitate…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.